Certain Components for Injection Molding Machines, and Products Containing the Same; Notice of a Commission Determination Not To Review an Initial Determination Finding Respondent Ningbo AO Sheng Mold Co., Ltd. in Default; Request for Written Submissions on Remedy, the Public Interest, and Bonding, 11437-11438 [2025-03591]

Download as PDF Federal Register / Vol. 90, No. 43 / Thursday, March 6, 2025 / Notices posting copies of the notice in the Office of the Secretary, U.S. International Trade Commission, Washington, DC, and by publishing the notice in the Federal Register of January 22, 2025 (90 FR 7702). The Commission conducted its conference on February 5, 2025. All persons who requested the opportunity were permitted to participate. The Commission made these determinations pursuant to §§ 703(a) and 733(a) of the Act (19 U.S.C. 1671b(a) and 1673b(a)). It completed and filed its determinations in these investigations on March 3, 2025. The views of the Commission are contained in USITC Publication 5597 (March 2025), entitled Temporary Steel Fencing from China: Investigation Nos. 701–TA– 754 and 731–TA–1732 (Preliminary). By order of the Commission. Issued: March 3, 2025. Lisa Barton, Secretary to the Commission. [FR Doc. 2025–03625 Filed 3–5–25; 8:45 am] BILLING CODE 7020–02–P INTERNATIONAL TRADE COMMISSION [Investigation No. 337–TA–1427] Certain Components for Injection Molding Machines, and Products Containing the Same; Notice of a Commission Determination Not To Review an Initial Determination Finding Respondent Ningbo AO Sheng Mold Co., Ltd. in Default; Request for Written Submissions on Remedy, the Public Interest, and Bonding U.S. International Trade Commission. ACTION: Notice. AGENCY: Notice is hereby given that the U.S. International Trade Commission has determined not to review an initial determination (‘‘ID’’) (Order No. 7) issued by the presiding chief administrative law judge (‘‘CALJ’’) finding respondent Ningbo AO Sheng Mold Co., Ltd., d/b/a AOSIMI (‘‘AOSIMI’’) to be in default, and to request written submissions from the parties, interested government agencies, and interested persons, under the schedule set forth below, on remedy, the public interest, and bonding. FOR FURTHER INFORMATION CONTACT: Paul Lall, Office of the General Counsel, U.S. International Trade Commission, 500 E Street SW, Washington, DC 20436, telephone (202) 205–2043. Copies of non-confidential documents filed in connection with this investigation may be viewed on the Commission’s lotter on DSK11XQN23PROD with NOTICES1 SUMMARY: VerDate Sep<11>2014 16:42 Mar 05, 2025 Jkt 265001 electronic docket (EDIS) at https:// edis.usitc.gov. For help accessing EDIS, please email EDIS3Help@usitc.gov. General information concerning the Commission may also be obtained by accessing its internet server at https:// www.usitc.gov. Hearing-impaired persons are advised that information on this matter can be obtained by contacting the Commission’s TDD terminal, telephone (202) 205–1810. SUPPLEMENTARY INFORMATION: On December 18, 2024, the Commission instituted this investigation under section 337 of the Tariff Act of 1930, as amended, 19 U.S.C. 1337 (‘‘section 337’’), based on a complaint filed by Husky Injection Molding Systems Ltd. of Canada and Husky Injection Molding Systems, Inc. of Milton, Vermont (collectively, ‘‘Complainants’’). See 89 FR 102953–54 (Dec. 18, 2024). The complaint alleges violations of section 337 based upon the importation into the United States, the sale for importation, and the sale within the United States after importation of certain components for injection molding machines, and products containing the same by reason of the infringement of certain claims of U.S. Patent Nos. 9,713,891, 11,794,375, 10,093,053, 8,834,149 and 7,645,132 (the ‘‘Asserted Patents’’). Id. at 102953. The Commission’s notice of investigation (‘‘NOI’’) named AOSIMI of Yuyao, Zhejiang, China as the sole respondent. Id. at 102954. AOSIMI did not respond to the complaint. On January 17, 2025, Complainants filed a motion for an order to show cause (‘‘Motion’’) demonstrating why AOSIMI should not be found in default for failing to respond to the Complaint and NOI. Complainants’ Motion explains that the complaint and NOI were delivered to AOSIMI via international FedEx and signed by a person in AOSIMI’s mail room named ‘‘M. Menwei.’’ Compls.’ Mem. in Support of Mot. for Order to Cause, at 2 (Jan. 17, 2025) (citing Proof of Service, EDIS Doc. ID 839378, at 5). On January 24, 2025, the CALJ issued an order directing AOSIMI to show cause, no later than February 7, 2025, why it should not be found in default for failing to respond to the complaint and NOI. ID at 1 (citing Order No. 5). On the same day, the Commission served Order No. 5 on AOSIMI via express mail to the address identified in the NOI. EDIS Doc. ID 841764. AOSIMI did not respond to the order to show cause. On February 14, 2025, the presiding CALJ issued the subject ID (Order No. 7) finding respondent AOSIMI to be in default pursuant to Commission Rule 210.16(b) (19 CFR 210.16(b)) and PO 00000 Frm 00041 Fmt 4703 Sfmt 4703 11437 terminating the investigation before the CALJ. No party filed a petition for review of the subject ID. The Commission has determined not to review the subject ID. The Commission finds that Ningbo AO Sheng Mold Co., Ltd. is properly found to be in default. In connection with the final disposition of this investigation, the statute authorizes issuance of, inter alia, (1) an exclusion order that could result in the exclusion of the subject articles from entry into the United States; and/ or (2) cease and desist orders that could result in the respondents being required to cease and desist from engaging in unfair acts in the importation and sale of such articles. Accordingly, the Commission is interested in receiving written submissions that address the form of remedy, if any, that should be ordered. If a party seeks exclusion of an article from entry into the United States for purposes other than entry for consumption, the party should so indicate and provide information establishing that activities involving other types of entry either are adversely affecting it or likely to do so. For background, see Certain Devices for Connecting Computers via Telephone Lines, Inv. No. 337–TA–360, USITC Pub. No. 2843, Comm’n Op. at 7–10 (Dec. 1994). The statute requires the Commission to consider the effects of that remedy upon the public interest. The public interest factors the Commission will consider include the effect that an exclusion order and cease and desist orders would have on: (1) the public health and welfare, (2) competitive conditions in the U.S. economy, (3) U.S. production of articles that are like or directly competitive with those that are subject to investigation, and (4) U.S. consumers. The Commission is therefore interested in receiving written submissions that address the aforementioned public interest factors in the context of this investigation. If the Commission orders some form of remedy, the U.S. Trade Representative, as delegated by the President, has 60 days to approve, disapprove, or take no action on the Commission’s determination. See Presidential Memorandum of July 21, 2005, 70 FR 43251 (July 26, 2005). During this period, the subject articles would be entitled to enter the United States under bond, in an amount determined by the Commission and prescribed by the Secretary of the Treasury. The Commission is therefore interested in receiving submissions concerning the amount of the bond that E:\FR\FM\06MRN1.SGM 06MRN1 lotter on DSK11XQN23PROD with NOTICES1 11438 Federal Register / Vol. 90, No. 43 / Thursday, March 6, 2025 / Notices should be imposed if a remedy is ordered. Written Submissions: Parties to the investigation, interested government agencies, and any other interested parties are encouraged to file written submissions on the issues of remedy, the public interest, and bonding. In their initial submission, Complainants are also requested to identify the remedy sought and Complainants are requested to submit proposed remedial orders for the Commission’s consideration. Complainants are further requested to state the dates that the Asserted Patents expire, to provide the HTSUS subheadings under which the accused products are imported, and to supply the identification information for all known importers of the products at issue in this investigation. The initial written submissions and proposed remedial orders must be filed no later than close of business on March 14, 2025. Reply submissions must be filed no later than the close of business on March 21, 2025. No further submissions on any of these issues will be permitted unless otherwise ordered by the Commission. Persons filing written submissions must file the original document electronically on or before the deadlines stated above pursuant to 19 CFR 210.4(f). Submissions should refer to the investigation number (‘‘Inv. No. 337– TA–1427’’) in a prominent place on the cover page and/or the first page. (See Handbook for Electronic Filing Procedures, https://www.usitc.gov/ documents/handbook_on_filing_ procedures.pdf). Persons with questions regarding filing should contact the Secretary, (202) 205–2000. Any person desiring to submit a document to the Commission in confidence must request confidential treatment by marking each document with a header indicating that the document contains confidential information. This marking will be deemed to satisfy the request procedure set forth in Rules 201.6(b) and 210.5(e)(2) (19 CFR 201.6(b) & 210.5(e)(2)). Documents for which confidential treatment by the Commission is properly sought will be treated accordingly. Any non-party wishing to submit comments containing confidential information must serve those comments on the parties to the investigation pursuant to the applicable Administrative Protective Order. A redacted non-confidential version of the document must also be filed with the Commission and served on any parties to the investigation within two business days of any confidential filing. All information, including confidential VerDate Sep<11>2014 16:42 Mar 05, 2025 Jkt 265001 business information and documents for which confidential treatment is properly sought, submitted to the Commission for purposes of this investigation may be disclosed to and used: (i) by the Commission, its employees and Offices, and contract personnel (a) for developing or maintaining the records of this or a related proceeding, or (b) in internal investigations, audits, reviews, and evaluations relating to the programs, personnel, and operations of the Commission including under 5 U.S.C. appendix 3; or (ii) by U.S. Government employees and contract personnel, solely for cybersecurity purposes. All contract personnel will sign appropriate nondisclosure agreements. All nonconfidential written submissions will be available for public inspection on EDIS. The Commission’s vote for this determination took place on February 28, 2025. The authority for the Commission’s determination is contained in section 337 of the Tariff Act of 1930, as amended (19 U.S.C. 1337), and in part 210 of the Commission’s Rules of Practice and Procedure (19 CFR part 210). By order of the Commission. Issued: February 28, 2025. Lisa Barton, Secretary to the Commission. comments be submitted electronically through the Federal eRulemaking Portal, which provides the ability to type short comments directly into the comment field on the web page or attach a file for lengthier comments. Please go to https://www.regulations.gov and follow the online instructions at that site for submitting comments. Upon submission of your comment, you will receive a Comment Tracking Number. Please be aware that submitted comments are not instantaneously available for public view on https://www.regulations.gov. If you have received a Comment Tracking Number, your comment has been successfully submitted and there is no need to resubmit the same comment. All requests for a hearing must be sent to: (1) Drug Enforcement Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, Springfield, Virginia 22152; and (2) Drug Enforcement Administration, Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a hearing should also be sent to: Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. In accordance with 21 CFR 1301.34(a), this is notice that on October 18, 2024, Indivior Inc., 2607 Midpoint Drive, Fort Collins, Colorado 80525–4427, applied to be registered as an importer of the following basic class(es) of controlled substance(s): SUPPLEMENTARY INFORMATION: [FR Doc. 2025–03591 Filed 3–5–25; 8:45 am] BILLING CODE 7020–02–P DEPARTMENT OF JUSTICE Drug Enforcement Administration Controlled substance Drug code Schedule [Docket No. DEA–1450] Thebaine .................... Importer of Controlled Substances Application: Indivior Inc. Drug Enforcement Administration, Justice. ACTION: Notice of application. AGENCY: Indivior Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information. DATES: Registered bulk manufacturers of the affected basic class(es), and applicants, therefore, may submit electronic comments on or objections to the issuance of the proposed registration on or before April 7, 2025. Such persons may also file a written request for a hearing on the application on or before April 7, 2025. ADDRESSES: The Drug Enforcement Administration requires that all SUMMARY: PO 00000 Frm 00042 Fmt 4703 Sfmt 9990 9333 II The company plans to import the listed controlled substance in limited quantity for research, clinical trials, analytical purposes, and for the manufacturing process development of the dosage form. No other activity for this drug code is authorized for this registration. Approval of permit applications will occur only when the registrant’s business activity is consistent with what is authorized under 21 U.S.C. 952(a)(2). Authorization will not extend to the import of Food and Drug Administration-approved or nonapproved finished dosage forms for commercial sale. Matthew Strait, Deputy Assistant Administrator. [FR Doc. 2025–03635 Filed 3–5–25; 8:45 am] BILLING CODE P E:\FR\FM\06MRN1.SGM 06MRN1

Agencies

[Federal Register Volume 90, Number 43 (Thursday, March 6, 2025)]
[Notices]
[Pages 11437-11438]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2025-03591]


-----------------------------------------------------------------------

INTERNATIONAL TRADE COMMISSION

[Investigation No. 337-TA-1427]


Certain Components for Injection Molding Machines, and Products 
Containing the Same; Notice of a Commission Determination Not To Review 
an Initial Determination Finding Respondent Ningbo AO Sheng Mold Co., 
Ltd. in Default; Request for Written Submissions on Remedy, the Public 
Interest, and Bonding

AGENCY: U.S. International Trade Commission.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: Notice is hereby given that the U.S. International Trade 
Commission has determined not to review an initial determination 
(``ID'') (Order No. 7) issued by the presiding chief administrative law 
judge (``CALJ'') finding respondent Ningbo AO Sheng Mold Co., Ltd., d/
b/a AOSIMI (``AOSIMI'') to be in default, and to request written 
submissions from the parties, interested government agencies, and 
interested persons, under the schedule set forth below, on remedy, the 
public interest, and bonding.

FOR FURTHER INFORMATION CONTACT: Paul Lall, Office of the General 
Counsel, U.S. International Trade Commission, 500 E Street SW, 
Washington, DC 20436, telephone (202) 205-2043. Copies of non-
confidential documents filed in connection with this investigation may 
be viewed on the Commission's electronic docket (EDIS) at https://edis.usitc.gov. For help accessing EDIS, please email 
[email protected]. General information concerning the Commission may 
also be obtained by accessing its internet server at https://www.usitc.gov. Hearing-impaired persons are advised that information on 
this matter can be obtained by contacting the Commission's TDD 
terminal, telephone (202) 205-1810.

SUPPLEMENTARY INFORMATION: On December 18, 2024, the Commission 
instituted this investigation under section 337 of the Tariff Act of 
1930, as amended, 19 U.S.C. 1337 (``section 337''), based on a 
complaint filed by Husky Injection Molding Systems Ltd. of Canada and 
Husky Injection Molding Systems, Inc. of Milton, Vermont (collectively, 
``Complainants''). See 89 FR 102953-54 (Dec. 18, 2024). The complaint 
alleges violations of section 337 based upon the importation into the 
United States, the sale for importation, and the sale within the United 
States after importation of certain components for injection molding 
machines, and products containing the same by reason of the 
infringement of certain claims of U.S. Patent Nos. 9,713,891, 
11,794,375, 10,093,053, 8,834,149 and 7,645,132 (the ``Asserted 
Patents''). Id. at 102953. The Commission's notice of investigation 
(``NOI'') named AOSIMI of Yuyao, Zhejiang, China as the sole 
respondent. Id. at 102954. AOSIMI did not respond to the complaint.
    On January 17, 2025, Complainants filed a motion for an order to 
show cause (``Motion'') demonstrating why AOSIMI should not be found in 
default for failing to respond to the Complaint and NOI. Complainants' 
Motion explains that the complaint and NOI were delivered to AOSIMI via 
international FedEx and signed by a person in AOSIMI's mail room named 
``M. Menwei.'' Compls.' Mem. in Support of Mot. for Order to Cause, at 
2 (Jan. 17, 2025) (citing Proof of Service, EDIS Doc. ID 839378, at 5). 
On January 24, 2025, the CALJ issued an order directing AOSIMI to show 
cause, no later than February 7, 2025, why it should not be found in 
default for failing to respond to the complaint and NOI. ID at 1 
(citing Order No. 5). On the same day, the Commission served Order No. 
5 on AOSIMI via express mail to the address identified in the NOI. EDIS 
Doc. ID 841764. AOSIMI did not respond to the order to show cause.
    On February 14, 2025, the presiding CALJ issued the subject ID 
(Order No. 7) finding respondent AOSIMI to be in default pursuant to 
Commission Rule 210.16(b) (19 CFR 210.16(b)) and terminating the 
investigation before the CALJ.
    No party filed a petition for review of the subject ID.
    The Commission has determined not to review the subject ID. The 
Commission finds that Ningbo AO Sheng Mold Co., Ltd. is properly found 
to be in default.
    In connection with the final disposition of this investigation, the 
statute authorizes issuance of, inter alia, (1) an exclusion order that 
could result in the exclusion of the subject articles from entry into 
the United States; and/or (2) cease and desist orders that could result 
in the respondents being required to cease and desist from engaging in 
unfair acts in the importation and sale of such articles. Accordingly, 
the Commission is interested in receiving written submissions that 
address the form of remedy, if any, that should be ordered. If a party 
seeks exclusion of an article from entry into the United States for 
purposes other than entry for consumption, the party should so indicate 
and provide information establishing that activities involving other 
types of entry either are adversely affecting it or likely to do so. 
For background, see Certain Devices for Connecting Computers via 
Telephone Lines, Inv. No. 337-TA-360, USITC Pub. No. 2843, Comm'n Op. 
at 7-10 (Dec. 1994).
    The statute requires the Commission to consider the effects of that 
remedy upon the public interest. The public interest factors the 
Commission will consider include the effect that an exclusion order and 
cease and desist orders would have on: (1) the public health and 
welfare, (2) competitive conditions in the U.S. economy, (3) U.S. 
production of articles that are like or directly competitive with those 
that are subject to investigation, and (4) U.S. consumers. The 
Commission is therefore interested in receiving written submissions 
that address the aforementioned public interest factors in the context 
of this investigation.
    If the Commission orders some form of remedy, the U.S. Trade 
Representative, as delegated by the President, has 60 days to approve, 
disapprove, or take no action on the Commission's determination. See 
Presidential Memorandum of July 21, 2005, 70 FR 43251 (July 26, 2005). 
During this period, the subject articles would be entitled to enter the 
United States under bond, in an amount determined by the Commission and 
prescribed by the Secretary of the Treasury. The Commission is 
therefore interested in receiving submissions concerning the amount of 
the bond that

[[Page 11438]]

should be imposed if a remedy is ordered.
    Written Submissions: Parties to the investigation, interested 
government agencies, and any other interested parties are encouraged to 
file written submissions on the issues of remedy, the public interest, 
and bonding. In their initial submission, Complainants are also 
requested to identify the remedy sought and Complainants are requested 
to submit proposed remedial orders for the Commission's consideration. 
Complainants are further requested to state the dates that the Asserted 
Patents expire, to provide the HTSUS subheadings under which the 
accused products are imported, and to supply the identification 
information for all known importers of the products at issue in this 
investigation. The initial written submissions and proposed remedial 
orders must be filed no later than close of business on March 14, 2025. 
Reply submissions must be filed no later than the close of business on 
March 21, 2025. No further submissions on any of these issues will be 
permitted unless otherwise ordered by the Commission.
    Persons filing written submissions must file the original document 
electronically on or before the deadlines stated above pursuant to 19 
CFR 210.4(f). Submissions should refer to the investigation number 
(``Inv. No. 337-TA-1427'') in a prominent place on the cover page and/
or the first page. (See Handbook for Electronic Filing Procedures, 
https://www.usitc.gov/documents/handbook_on_filing_procedures.pdf). 
Persons with questions regarding filing should contact the Secretary, 
(202) 205-2000.
    Any person desiring to submit a document to the Commission in 
confidence must request confidential treatment by marking each document 
with a header indicating that the document contains confidential 
information. This marking will be deemed to satisfy the request 
procedure set forth in Rules 201.6(b) and 210.5(e)(2) (19 CFR 201.6(b) 
& 210.5(e)(2)). Documents for which confidential treatment by the 
Commission is properly sought will be treated accordingly. Any non-
party wishing to submit comments containing confidential information 
must serve those comments on the parties to the investigation pursuant 
to the applicable Administrative Protective Order. A redacted non-
confidential version of the document must also be filed with the 
Commission and served on any parties to the investigation within two 
business days of any confidential filing. All information, including 
confidential business information and documents for which confidential 
treatment is properly sought, submitted to the Commission for purposes 
of this investigation may be disclosed to and used: (i) by the 
Commission, its employees and Offices, and contract personnel (a) for 
developing or maintaining the records of this or a related proceeding, 
or (b) in internal investigations, audits, reviews, and evaluations 
relating to the programs, personnel, and operations of the Commission 
including under 5 U.S.C. appendix 3; or (ii) by U.S. Government 
employees and contract personnel, solely for cybersecurity purposes. 
All contract personnel will sign appropriate nondisclosure agreements. 
All nonconfidential written submissions will be available for public 
inspection on EDIS.
    The Commission's vote for this determination took place on February 
28, 2025.
    The authority for the Commission's determination is contained in 
section 337 of the Tariff Act of 1930, as amended (19 U.S.C. 1337), and 
in part 210 of the Commission's Rules of Practice and Procedure (19 CFR 
part 210).

    By order of the Commission.

    Issued: February 28, 2025.
Lisa Barton,
Secretary to the Commission.
[FR Doc. 2025-03591 Filed 3-5-25; 8:45 am]
BILLING CODE 7020-02-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.